CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 235 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q2 2024. The put-call ratio across all filers is 1.79 and the average weighting 0.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 65,679,781 | $2,685,646,245 | 57.02% |
| Twin Securities, Inc. | 416,657 | $17,037,105 | 13.40% |
| Sand Grove Capital Management LLP | 919,023 | $37,578,850 | 10.99% |
| Perceptive Advisors | 10,794,876 | $441,402,480 | 10.63% |
| P SCHOENFELD ASSET MANAGEMENT LP | 796,440 | $32,566,432 | 7.87% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,353,694 | $96,242,547 | 4.60% |
| Avoro Capital Advisors LLC | 7,539,547 | $308,292,077 | 4.11% |
| Melqart Asset Management (UK) Ltd | 1,099,229 | $44,947,474 | 3.72% |
| Paradigm Biocapital Advisors LP | 2,330,508 | $95,294,472 | 3.65% |
| WATER ISLAND CAPITAL LLC | 766,933 | $31,360 | 3.33% |
| Affinity Asset Advisors, LLC | 500,000 | $20,445,000 | 2.36% |
| Vazirani Asset Management LLC | 25,000 | $1,022,250 | 2.18% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 192,150 | $7,857,014 | 2.16% |
| ClearAlpha Technologies LP | 149,438 | $6,110,520 | 2.02% |
| TIG Advisors, LLC | 588,255 | $24,053,747 | 1.73% |
| Trium Capital LLP | 317,731 | $12,992 | 1.64% |
| Soros Fund Management | 2,151,641 | $87,980,600 | 1.58% |
| Olympiad Research LP | 52,423 | $2,143,576 | 1.58% |
| STANSBERRY ASSET MANAGEMENT, LLC | 281,694 | $11,518,467 | 1.51% |
| HighVista Strategies LLC | 97,200 | $3,974,508 | 1.45% |
External links
This page lists CEREVEL THERAPEUTICS HLDNG I's shareholders in Q2 2024. To view CEREVEL THERAPEUTICS HLDNG I's shareholder history, click here.